About
Helixa builds programmable mRNA medicines for rare and infectious diseases, from target selection to first-in-human studies. Its open delivery platform is used by more than twenty academic partners.
In good company
Other sponsors
Become a sponsor
Headline, stream and exhibition packages are available for 2027.